Relypsa, Inc. to Present Phase 3 Data in Late-Breaking Poster Session at ASN Kidney Week 2013 Annual Meeting in Atlanta, GA
10/21/2013 7:18:34 AM
Relypsa, Inc., a clinical-stage biopharmaceutical company, today announced that the American Society of Nephrology (ASN) has accepted its abstract for the late-breaking clinical trial poster session of the ASN Kidney Week 2013 Annual Meeting in Atlanta, GA.
Help employers find you! Check out all the jobs and post your resume.